Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancer Treatment and Research Communications|February 3, 2020
Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lungHussein A Assi, Sukhmani K PaddaThe Journal of Community and Supportive Oncology|February 11, 2016
Neuroendocrine carcinoma of the larynx with metastasis to the eyelidHussein A Assi, Raina Patel, Syed MehdiAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
ASCO's International programs and how you can become involvedNagi S El Saghir, Hussein A Assi, Doug PyleAnticancer Research|February 5, 2020
Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer DatabaseHussein A Assi, Sarbajit Mukherjee, Michael Machiorlatti, et al.Future Science OA|August 18, 2020
Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapyHussein A Assi, Adam S Asch, Michael Machiorlatti, et al.Journal of Clinical and Translational Hepatology|December 2, 2015
Hepatobiliary Tumors: Update on Diagnosis and ManagementGhassan Kabbach, Hussein A Assi, George Bolotin, et al.Pancreas|August 16, 2021
Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine TumorsHussein A Assi, Kathleen Hornbacker, Shagufta Shaheen, et al.Breast Care (Basel, Switzerland)|January 14, 2014
Management of Paclitaxel-induced hand-foot syndromeHussein A Assi, Zeina A Ayoub, Sara M Jaber, et al.The Oncologist|February 12, 2020
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer DatabaseHussein A Assi, Sarbajit Mukherjee, Pamela L Kunz, et al.Surgical Pathology Clinics|September 1, 2022
Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine TumorsWenzel M Hackeng, Hussein A Assi, Florine H M Westerbeke, et al.Pageof 2